Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$23.07 - $32.77 $23.9 Million - $33.9 Million
1,035,910 New
1,035,910 $29.1 Billion
Q4 2022

Feb 14, 2023

BUY
$25.29 - $35.48 $30.9 Million - $43.3 Million
1,221,302 New
1,221,302 $30.9 Million
Q3 2022

Nov 14, 2022

SELL
$24.0 - $33.42 $243,048 - $338,444
-10,127 Reduced 0.98%
1,026,158 $29.5 Million
Q2 2022

Aug 15, 2022

BUY
$24.78 - $33.36 $25.7 Million - $34.6 Million
1,036,285 New
1,036,285 $26.2 Million

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.